Artigo de Revisão

Lists of potentially inappropriate medications for older people in primary care: a systematic review of health outcomes

Publicado em: 2024

Autores

  • Rafael Cardinali Rodrigues
    Secretaria de Saúde do Distrito Federal, Brasília, Brasil.
  • Gabrielle Kéfrem Alves Gomes
    Secretaria de Saúde do Distrito Federal, Brasília, Brasil.
  • Bárbara Manuella Cardoso Sodré
    Universidade de Brasília, Brasília, Brasil.
  • Rodrigo Fonseca Lima
    Universidade de Brasília, Brasília, Brasil.
  • Débora Santos Lula Barros
    Universidade de Brasília, Brasília, Brasil.
  • Ana Claudia Morais Godoy Figueiredo
    Escola Superior de Ciências da Saúde, Brasília, Brasil.
  • Cristine Miron Stefani
    Universidade de Brasília, Brasília, Brasil.
  • Dayde Lane Mendonça da Silva
    Universidade de Brasília, Brasília, Brasil.

Resumo

This study is a systematic literature review of the association between lists of potentially inappropriate medications (PIM) in clinical practice and health outcomes of older adults followed up in primary health care. For this purpose, the PRISMA protocol was used to systematize the search for articles in the PubMed, Web of Science, Scopus, Cochrane Central, LIVIVO and LILACS databases, in addition to the gray literature. Studies with randomized clinical trials were selected, using explicit criteria (lists) for the identification and management of PIM in prescriptions of older patients in primary care. Of the 2,400 articles found, six were used for data extraction. The interventions resulted in significant reductions in the number of PIM and adverse drug events and, consequently, in potentially inappropriate prescriptions (PIP) in polymedicated older adults. However, there were no significant effects of the interventions on negative clinical outcomes, such as emergency room visits, hospitalizations and death, or on improving the health status of the older adults. The use of PIM lists promotes adequate medication prescriptions for older adults in primary health care, but further studies are needed to determine the impact of reducing PIM on primary clinical outcomes.

Utilizamos cookies para melhorar sua experiência. Ao navegar, você concorda com nossa Política de Privacidade. Ler Política

Painel de Acessibilidade

Ajuste sua experiência de navegação

LIBRAS

ASSISTÊNCIA VISUAL

Tamanho da Fonte

100%